KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Short-term Investments (2018 - 2024)

BioNTech SE's Short-term Investments history spans 7 years, with the latest figure at $7.5 billion for Q4 2024.

  • For Q4 2024, Short-term Investments rose 42.75% year-over-year to $7.5 billion; the TTM value through Dec 2024 reached $7.5 billion, up 42.75%, while the annual FY2024 figure was $7.6 billion, 43.81% up from the prior year.
  • Short-term Investments for Q4 2024 was $7.5 billion at BioNTech SE, up from $5.3 billion in the prior quarter.
  • Across five years, Short-term Investments topped out at $14.6 billion in Q4 2021 and bottomed at $163.6 million in Q4 2020.
  • The 5-year median for Short-term Investments is $5.3 billion (2023), against an average of $5.5 billion.
  • The largest annual shift saw Short-term Investments skyrocketed 8825.69% in 2021 before it crashed 98.68% in 2022.
  • A 5-year view of Short-term Investments shows it stood at $163.6 million in 2020, then surged by 8825.69% to $14.6 billion in 2021, then plummeted by 98.68% to $193.2 million in 2022, then soared by 2620.16% to $5.3 billion in 2023, then skyrocketed by 42.75% to $7.5 billion in 2024.
  • Per Business Quant, the three most recent readings for BNTX's Short-term Investments are $7.5 billion (Q4 2024), $5.3 billion (Q4 2023), and $193.2 million (Q4 2022).